| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2969615 | The Journal of Heart and Lung Transplantation | 2016 | 8 Pages |
Abstract
In our experience, the sensitivity of biopsies from non-affected organs in ACAL is poor and could result in diagnostic delay. Bortezomib was associated with higher hematologic and cardiac response rates as well as survival when compared with other therapies.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Inés MD, Isabel MD, PhD, Manuel MD, Pablo MD, PhD, Natalia MD, Clara MD, PhD, Susana MD, PhD, Juan F. MD, Luis MD, PhD, Javier MD, PhD,